Hematology TimesEculizumab gets accelerated approval for aHUSSeptember 23, 2011AnemiaThrombosisPediatricsPharmacy
Hematology TimesNewly identified NHP2 biallelic mutation can cause dyskeratosis congenitaJune 26, 2008Anemia
Hematology TimesEculizumab decreases risk of thrombosis in PNHJuly 6, 2007AnemiaThrombosisBleeding Disorders
Hematology TimesRaising hemoglobin levels to normal range for chronic kidney failure patients may be too riskyMarch 1, 2007Anemia
